Position in DTIL
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$1,692,845
+$1,112,397 QoQ
Shares Held
307,790
+120.6% QoQ
Ownership
1.19%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#11
of 78 holders
Holding Since
Mar 2025
5 quarters on record
Voting authority
Sole 98.17440462653107.ToString("F0")%
Shared 0.ToString("F0")%
None 1.8255953734689234.ToString("F0")%
Common Shares in DTIL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026TWO SIGMA INVESTMENTS, LP holds $5,509,413,147 across 314 Biotechnology names. DTIL ranks #166 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
1,992,577 | $659,283,951 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
812,236 | $627,566,023 | |
| 3 | MRNA |
Moderna, Inc.
|
9,086,404 | $461,589,323 | |
| 4 | IONS |
Ionis Pharmaceuticals Inc
|
5,857,629 | $439,849,361 | |
| 5 | BBIO |
BridgeBio Pharma, Inc.
|
3,120,631 | $231,738,058 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
378,146 | $168,857,314 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,558,807 | $151,593,980 | |
| 8 | VKTX |
Viking Therapeutics, Inc.
|
4,432,142 | $144,221,900 |
All Filings in DTIL
Export CSV
5 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,692,845 | 307,790 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $580,448 | 139,531 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $458,667 | 83,092 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $68,724 | 16,363 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $64,705 | 13,565 | Shares | Sole | 2025-05-15 | |
| No filing history on record for this holder in this stock. | ||||||